まとめ
レチノ酸はF9胚性がん細胞の分化を引き起こし,形態の変化やコラーゲン合成の増加などの表型変化を引き起こす. これは,レチノ酸が幹細胞の分化を内皮に駆り立てる可能性があることを示唆しています.
科学分野:
- 発達生物学 発達生物学とは
- 幹細胞生物学 幹細胞生物学
- がん研究 がん研究
背景:
- 胚性がん (EC) 細胞は,テラトカルシノーマの幹細胞であり,典型的には広範に微分化しています.
- F9のようないくつかのEC細胞系は,分化能力が低下し,幹細胞の特性を維持しています.
- これらの細胞系における微分化を誘発する要因を理解することは,発達およびがん研究にとって極めて重要です.
研究 の 目的:
- レチノ酸がF9胚性がん細胞の分化に及ぼす影響を調査する.
- レチノ酸によって誘発された特定のフェノタイプの変化を in vitro で特定するために.
- レチノ酸が内皮への分化経路を開始できるかどうかを判断する.
主な方法:
- 低濃度のレチノ酸 (10(-9) M) を含有したF9胚性がん細胞の治療 in vitro.
- 光顕微鏡を用いた形態学的変化の観察.
- プラズミノゲンアクティベーター生産の測定.
- 循環型AMP化合物に対する感受性の評価.
- コラーゲン型のタンパク質合成の分析.
主要な成果:
- レチノ酸は,F9細胞の重要な形態学的変化を引き起こした.
- プラズミノゲン活性化剤のレベルが上昇することが観察されました.
- 細胞は,循環型AMPに対する感受性が高まった.
- コラーゲンのようなタンパク質の合成が強化されました.
- これらの誘発された変化は,レチノ酸を除去した後でも持続しました.
結論:
- レチノ酸は,F9胚性がん細胞の微分化を効果的に誘導する.
- 誘発された差異化には,形態的および分子的変化を含む複数の現象的変化が含まれます.
- この発見は,EC幹細胞からの内皮分化を促進するレチノ酸の役割を裏付けています.
関連する概念動画
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Chemotaxis and Direction of Cell Migration
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.


